FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968479003> ?p ?o ?g. }

• W1968479003 endingPage "66" @default.
• W1968479003 startingPage "57" @default.
• W1968479003 abstract "Cystic fibrosis (CF) is an autosomal recessive disorder caused by many types of genetic defects, including premature stop codons. Gentamicin can suppress stop mutations in CF transmembrane conductance regulator (CFTR) in vitro and in vivo, leading to improvements in CFTR-dependent ion transport and protein localization to the apical surface of respiratory epithelial cells. The primary objective of this study was to test whether nasally administered gentamicin or tobramycin could suppress premature stop mutations in CFTR, resulting in full-length, functional protein. A secondary objective was to obtain data to aid in the design of multicenter trials using the nasal potential difference as a study endpoint. A multicenter study was conducted in two cohorts of patients with CF, those heterozygous for stop mutations in the CFTR gene and those without nonsense mutations, to investigate the effects of both gentamicin and tobramycin administered over a 28-d period on sequential nasal potential difference and airway cell immunofluorescence endpoints. Eleven patients with CF with stop mutations were enrolled in a randomized, double-blinded, crossover fashion to receive each drug, while 18 subjects with CF without stop mutations were randomized 1:1 in a parallel fashion to receive one drug. After demonstration of drug delivery, neither aminoglycoside produced detectable changes in nasal ion transport or CFTR localization in brushed cells from either study group. These results with first-generation suppressive agents suggest the need for improved drug delivery methods and/or more potent suppressors of nonsense mutations to confer CFTR correction in subjects with CF heterozygous for nonsense mutations. The study provides valuable information on parameters of the nasal potential difference measurements for use in future multicenter clinical trials." @default.
• W1968479003 created "2016-06-24" @default.
• W1968479003 creator A5000385368 @default.
• W1968479003 creator A5001508577 @default.
• W1968479003 creator A5008375832 @default.
• W1968479003 creator A5008478108 @default.
• W1968479003 creator A5052055623 @default.
• W1968479003 creator A5055982974 @default.
• W1968479003 creator A5059949414 @default.
• W1968479003 creator A5062599923 @default.
• W1968479003 creator A5069900524 @default.
• W1968479003 creator A5082672834 @default.
• W1968479003 creator A5082827731 @default.
• W1968479003 creator A5089990546 @default.
• W1968479003 date "2007-07-01" @default.
• W1968479003 modified "2023-10-17" @default.
• W1968479003 title "No Detectable Improvements in Cystic Fibrosis Transmembrane Conductance Regulator by Nasal Aminoglycosides in Patients with Cystic Fibrosis with Stop Mutations" @default.
• W1968479003 cites W185124257 @default.
• W1968479003 cites W1979646418 @default.
• W1968479003 cites W1983530499 @default.
• W1968479003 cites W1989615102 @default.
• W1968479003 cites W2008191147 @default.
• W1968479003 cites W2012514866 @default.
• W1968479003 cites W2020494747 @default.
• W1968479003 cites W2029368934 @default.
• W1968479003 cites W2036293054 @default.
• W1968479003 cites W2041380439 @default.
• W1968479003 cites W2054592934 @default.
• W1968479003 cites W2069289373 @default.
• W1968479003 cites W2071226544 @default.
• W1968479003 cites W2072335937 @default.
• W1968479003 cites W2076934605 @default.
• W1968479003 cites W2087360813 @default.
• W1968479003 cites W2092985615 @default.
• W1968479003 cites W2120634007 @default.
• W1968479003 cites W2120906365 @default.
• W1968479003 cites W2123767456 @default.
• W1968479003 cites W2131056651 @default.
• W1968479003 cites W2138022079 @default.
• W1968479003 cites W2139691229 @default.
• W1968479003 cites W2141439233 @default.
• W1968479003 cites W2145165965 @default.
• W1968479003 cites W2158010208 @default.
• W1968479003 cites W2158494985 @default.
• W1968479003 cites W2160066700 @default.
• W1968479003 cites W2160400422 @default.
• W1968479003 cites W306911827 @default.
• W1968479003 cites W4252200392 @default.
• W1968479003 doi "https://doi.org/10.1165/rcmb.2006-0173oc" @default.
• W1968479003 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1899350" @default.
• W1968479003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17347447" @default.
• W1968479003 hasPublicationYear "2007" @default.
• W1968479003 type Work @default.
• W1968479003 sameAs 1968479003 @default.
• W1968479003 citedByCount "81" @default.
• W1968479003 countsByYear W19684790032012 @default.
• W1968479003 countsByYear W19684790032013 @default.
• W1968479003 countsByYear W19684790032014 @default.
• W1968479003 countsByYear W19684790032015 @default.
• W1968479003 countsByYear W19684790032016 @default.
• W1968479003 countsByYear W19684790032017 @default.
• W1968479003 countsByYear W19684790032018 @default.
• W1968479003 countsByYear W19684790032019 @default.
• W1968479003 countsByYear W19684790032020 @default.
• W1968479003 countsByYear W19684790032021 @default.
• W1968479003 countsByYear W19684790032022 @default.
• W1968479003 countsByYear W19684790032023 @default.
• W1968479003 crossrefType "journal-article" @default.
• W1968479003 hasAuthorship W1968479003A5000385368 @default.
• W1968479003 hasAuthorship W1968479003A5001508577 @default.
• W1968479003 hasAuthorship W1968479003A5008375832 @default.
• W1968479003 hasAuthorship W1968479003A5008478108 @default.
• W1968479003 hasAuthorship W1968479003A5052055623 @default.
• W1968479003 hasAuthorship W1968479003A5055982974 @default.
• W1968479003 hasAuthorship W1968479003A5059949414 @default.
• W1968479003 hasAuthorship W1968479003A5062599923 @default.
• W1968479003 hasAuthorship W1968479003A5069900524 @default.
• W1968479003 hasAuthorship W1968479003A5082672834 @default.
• W1968479003 hasAuthorship W1968479003A5082827731 @default.
• W1968479003 hasAuthorship W1968479003A5089990546 @default.
• W1968479003 hasBestOaLocation W19684790032 @default.
• W1968479003 hasConcept C104317684 @default.
• W1968479003 hasConcept C12125453 @default.
• W1968479003 hasConcept C126322002 @default.
• W1968479003 hasConcept C203014093 @default.
• W1968479003 hasConcept C2775832221 @default.
• W1968479003 hasConcept C2776502428 @default.
• W1968479003 hasConcept C2776938444 @default.
• W1968479003 hasConcept C2777787772 @default.
• W1968479003 hasConcept C2778428886 @default.
• W1968479003 hasConcept C2778974779 @default.
• W1968479003 hasConcept C501593827 @default.
• W1968479003 hasConcept C501734568 @default.
• W1968479003 hasConcept C54355233 @default.
• W1968479003 hasConcept C71924100 @default.
• W1968479003 hasConcept C75563809 @default.
• W1968479003 hasConcept C86803240 @default.
• W1968479003 hasConcept C96777560 @default.

• next